EFFECT OF PROTEIN-BINDING ON CEFMENOXIME STEADY-STATE KINETICS IN CRITICAL PATIENTS

被引：22

作者：

REITBERG, DP

CUMBO, TJ

SMITH, IL

SCHENTAG, JJ

机构：

[1] MILLARD FILLMORE HOSP,CLIN PHARMACOKINET LAB,BUFFALO,NY 14209

[2] MILLARD FILLMORE HOSP,DEPT MED,BUFFALO,NY 14209

[3] SUNY BUFFALO,DEPT PHARMACEUT,DIV CLIN PHARM SCI,BUFFALO,NY 14260

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 01期

关键词：

D O I：

10.1038/clpt.1984.10

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：64 / 73

页数：10

共 19 条

[1]

COCKCROFT DW, 1976, NEPHROLOGIE, V16, P34

[2] PROTEIN-BINDING OF ANTIMICROBIALS - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS [J].

CRAIG, WA ;

WELLING, PG .

CLINICAL PHARMACOKINETICS, 1977, 2 (04) :252-268

[3]

DUDLEY MN, 1982, NEW BETA LACTAM ANTI, P227

[4] CEFMENOXIME (SCE-1365), A NEW CEPHALOSPORIN - INVITRO ACTIVITY, COMPARISON WITH OTHER ANTIMICROBIAL AGENTS, BETA-LACTAMASE STABILITY, AND DISK DIFFUSION TESTING WITH TENTATIVE INTERPRETIVE CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

THORNSBERRY, C ;

BARRY, AL ;

GERLACH, EH ;

SOMMERS, HM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (06) :747-759

[5]

Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[6] INTRAMUSCULAR AND INTRAVENOUS PHARMACOKINETICS OF CEFMENOXIME, A NEW BROAD-SPECTRUM CEPHALOSPORIN, IN HEALTHY-SUBJECTS [J].

GRANNEMAN, GR ;

SENNELLO, LT ;

STEINBERG, FJ ;

SONDERS, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :141-145

[7]

Jusko WJ, 1980, APPLIED PHARMACOKINE, P639

[8]

LEROY A, 1982, 22ND INT C ANT AG CH

[9] THE INVITRO ACTIVITY, HUMAN PHARMACOLOGY, AND CLINICAL EFFECTIVENESS OF NEW BETA-LACTAM ANTIBIOTICS [J].

NEU, HC .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1982, 22 :599-642

[10]

ODARCEDERLOF I, 1976, CLIN PHARMACOL THER, V20, P36

← 1 2 →